N4 Pharma Plc (AIM:N4P)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.5000
-0.0250 (-4.76%)
Mar 5, 2026, 3:10 PM GMT

N4 Pharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4224815
Market Cap Growth
92.49%-9.28%-47.17%-46.33%-46.71%441.90%
Enterprise Value
3113613
Last Close Price
0.010.010.010.020.040.08
PS Ratio
618.38284.621169.81---
PB Ratio
2.473.181.912.073.784.13
P/TBV Ratio
2.473.202.142.073.784.13
EV/Sales Ratio
-123.16509.40---
Net Debt / Equity Ratio
-0.98-0.96-0.86-0.92-0.84-0.97
Asset Turnover
0.000.010.00---
Quick Ratio
23.556.1214.7327.3410.9822.54
Current Ratio
23.556.2414.8627.8111.0122.63
Return on Equity (ROE)
-74.18%-121.41%-77.81%-48.80%-53.37%-56.19%
Return on Assets (ROA)
-47.21%-74.42%-48.50%-33.08%-37.35%-39.98%
Return on Capital Employed (ROCE)
-68.00%-187.50%-111.90%-57.10%-86.60%-42.80%
Earnings Yield
-25.23%-51.08%-55.56%-23.80%-19.16%-8.63%
Buyback Yield / Dilution
-80.86%-40.34%-30.29%-2.95%-32.85%-36.08%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.